|
|
|
|
| Advertisement |
A Modern Approach to Global Growth & Compliance in Life Sciences: A Story of Digitalization at Boehringer Ingelheim
 On Demand
|
|
| Special Feature |
 |
|
Pharm Exec’s Pipeline Report 2020 |
Our Annual Pipeline Report examines six key areas of biopharma R&D where promising research efforts are now beginning to pay dividends, as novel advances in science usher in new treatment approaches and curative therapies
… /Read more/ |
|
|
|
| Audio |
 |
|
|
|
| Calendar |
|
/ February 27–28, 2020: Pharmaceutical Compliance Congress Asia / |
|
Kyoto, Japan |
|
/ March 8-11, 2020: Pharma Forum 2020 / |
|
New York City, NY |
|
/ March 18–19 2020: World Pharma Pricing Market Access & Evidence Congress / |
|
Amsterdam, The Netherlands |
|
/ March 18–19, 2020: World Pharma Pricing Market Access & Evidence Congress / |
|
Amsterdam, The Netherlands |
|
/ March 30–31, 2020: 6th Edition Drug Pricing Transparency Congress / |
|
Philadelphia, PA |
|
/ March 31–April 2, 2020: eyeforpharma Barcelona 2020 / |
|
Barcelona, Spain |
|
|
| Industry update |
| // Clinical stage biotechnology company Destiny Pharma (Brighton, UK) appointed Dr. Debra Barker as an independent Non-Executive Director, effective January 1, 2020.
// PharmaVentures (Oxford, UK) appointed Mark Andrews as a Managing Director.
// Arctoris Ltd (Oxford, UK) announced the appointments of Professor John Mattick as a Member of the Board of Directors and Daniel Thomas Ph.D., LCGI as Head of Discovery Biology.
// Myeloma UK (Edinburgh, UK) appointed Sarah McDonald as its new Director of Research.
// Valneva (Saint Herblain, France), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, announced the appointment of Dr. Norman W. Baylor and Dr. George R. Siber to its Scientific Advisory Board.
// Orexo AB (Uppsala, Sweden) appointed Dennis Urbaniak as Executive Vice President of Digital Health.
|
|
|
|
|
|
|
|
|
Register Now
